GENEVA, Aug. 5 -- MEDIMABBIO INC. (#721, 54, Changeop-ro,Sujeong-gu, Seongnam-si,Gyeonggi-do 13449), 메디맵바이오 주식회사 (경기도성남시 수정구창업로 54, 721호) filed a patent application (PCT/KR2025/001532) for "ANTI-TIGIT ANTIBODY SPECIFICALLY BINDING TO TIGIT, FUSION PROTEIN COMPRISING SAME AND INTERLEUKIN-10, AND USES THEREOF" on Jan 24, 2025. With publication no. WO/2025/159595, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectua...